Cyclerion Therapeutics Inc

NASDAQ:CYCN   1:15:33 PM EDT
3.44
+0.19 (+5.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cyclerion Therapeutics Inc Stock, NASDAQ:CYCN

Riverview II, 245 First Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.327.8778
Number of Employees: 34

Description

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.